etofibrate has been researched along with Diabetes Mellitus, Adult-Onset in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dietlein, M; Geiss, HC; Parhofer, KG | 1 |
Freyberger, H; Schatz, H; Schifferdecker, E | 1 |
Fenselau, S; Schrezenmeir, J; Steinmetz, A | 1 |
1 review(s) available for etofibrate and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Treatment of dyslipoproteinemia in the metabolic syndrome.
Topics: Arteriosclerosis; Clofibric Acid; Coronary Disease; Diabetes Mellitus, Type 2; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Metabolic Syndrome | 2001 |
1 trial(s) available for etofibrate and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Influence of etofibrate on LDL-subtype distribution in patients with diabetic dyslipoproteinemia.
Topics: Adult; Aged; Body Mass Index; Cholesterol; Cholesterol, HDL; Clofibric Acid; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Triglycerides | 2003 |
1 other study(ies) available for etofibrate and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
[Regression of hard exudates in diabetic background retinopathy in therapy with etofibrate antilipemic agent].
Topics: Adult; Blood Glucose; Clofibric Acid; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fundus Oculi; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Male; Middle Aged; Pilot Projects | 1994 |